Methods of determining dosing of a therapeutic agent based on measured levels of a metabolite
AssigneeClear Creek Bio, Inc.
InventorsVikram S. Kumar, David P. Hesson
Life of this patent
Estimating the term…
Loading patent…
AssigneeClear Creek Bio, Inc.
InventorsVikram S. Kumar, David P. Hesson
Estimating the term…
The invention provides methods of determining a therapeutically effective dose of an agent that targets a metabolic pathway based on measured levels of a metabolite in the pathway. The methods, which may include providing the agent in a therapeutically effective dose, are useful for treating disorders, such as cancer, in a subject. The invention also provides methods for assessing the impact of a therapeutic agent on a tumor in a subject by monitoring, in real time, metabolism of a molecule in the tumor, oxygenation of the tumor, or both. The invention further provides devices that determine a therapeutically effective dose of an agent that targets a metabolic pathway based on measured levels of a metabolite in the pathway and notify a subject to administer the dose.
A method for determining a therapeutically effective dose of an agent to treat a disorder, the method comprising:
A method of determining a therapeutically effective dose of an agent to be provided to a subject to treat a disorder, the method comprising:
A method for assessing in real-time an impact on a tumor of a therapeutic agent, the method comprising:
A device comprising a processor and a memory unit operably coupled to the processor to cause the processor to:
A method for assessing in real-time an impact on a tumor of a therapeutic agent, the method comprising:
A method for assessing in real-time an impact on a tumor of a therapeutic agent, the method comprising:
Dependencies are inferred from the claim text.